Hebei Changshan Biochemical Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ENOXAPARIN SODIUM, with a corresponding US DMF Number 26258.
Remarkably, this DMF maintains an Active status since its submission on July 30, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 18, 2015, and payment made on April 30, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II